Exosens : Favourable trend in Q3 lends weight to scenario of meeting FY targets
>Q3: continued solid momentum in Amplification and much more satisfactory organic growth in DI - This morning, Exosens reported Q3 sales close to our expectations, up 43% (+29% on a reported basis) at € 88m (vs € 90m est.). By business unit (BU), we retain: 1/ Amplification (70% of Q3 sales) posted sales of € 62m, up 36% y-o-y underpinned by still favourable trends in volumes (Theon contract / Germany notably) and a positive product mix effect (4G/4G+). 2/ Detection &...
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.